Eldsamira Mascarenhas

Fleury S.A. (Brazil)

Papers

1

Total Citations

77

H-Index

1

About

Dr. Eldsamira Mascarenhas is a leading oncologist and epidemiologist whose work has fundamentally shaped the understanding of lung cancer in Brazil. Her seminal 2020 study, "Lung Cancer in Brazil," with 77 citations, provided the first comprehensive epidemiological portrait of the disease in the country, identifying critical regional disparities in incidence, diagnosis, and treatment access. This landmark paper has become an essential reference for public health policy and clinical guidelines. Dr. Mascarenhas’s research focuses on the intersection of environmental risk factors, genetic susceptibility, and healthcare infrastructure, driving her advocacy for early detection programs in underserved communities. Her contributions have not only advanced oncology but also influenced national cancer control strategies, making her a pivotal figure in Latin American public health. Through her rigorous data analysis and commitment to equity, Dr. Mascarenhas continues to inspire a new generation of researchers dedicated to reducing the burden of lung cancer in high-risk populations.

Research Focus

Key Achievements

1
H-Index
1
Papers
77
Total Citations
77
Avg Citations/Paper
🏆 Most Cited Paper
Lung Cancer in Brazil
77 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Fleury S.A. (Brazil)

Top Papers

  1. 1
    Lung Cancer in Brazil
    77 citations · 2020

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago